The Medical and Scientific Professionals team at AMLo Biosciences is focused on advancing research and validation of prognostic testing for early-stage melanoma. Comprising experts in scientific leadership, histopathology, medical communication, and laboratory operations, this team ensures the accuracy and reliability of diagnostic tools while providing critical insights into disease progression and patient management. Their collective expertise drives the development of innovative solutions to enhance patient outcomes in melanoma care.
View all